Celldex Therapeutics reported $14.56M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Amgen AMGN:US $ 12886M 702M
Applied Genetic Technologies AGTC:US $ 25.81M 1.7M
Aptinyx Inc APTX:US $ 4.74M 949K
Biocept BIOC:US $ 14.1M 2.32M
Celldex Therapeutics CLDX:US $ 14.56M 1.97M
Cytrx CYTR:US 3.1M 633.56K
Glaxosmithkline GSK:US $ 24278M 608M
Immunogen IMGN:US $ 84.12M 16.83M
Nektar Therapeutics NKTR:US $ 85.2M 54.77M
Newlink Genetics NLNK:US $ 5.24M 0.11M
Northwest Biotherapeutics NWBO:US 130.01M 3.76M